The pharmacology and use of H1-receptor-antagonist drugs

New England Journal of Medicine

Volumn 330, Issue 23, 1994, Pages 1663-1670

  Wood, Alastair J j ^a   Simons, F Estelle R ^b   Simons, Keith J ^b  

^a University of Manitoba ^*

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ASTEMIZOLE; AZELASTINE; CETIRIZINE; CHLORPHENIRAMINE MALEATE; CLARITHROMYCIN; CYTOCHROME P450; DIPHENHYDRAMINE; ERYTHROMYCIN; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; ITRACONAZOLE; KETOCONAZOLE; KETOTIFEN FUMARATE; LEVOCABASTINE; LORATADINE; TERFENADINE;

ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ANTICHOLINERGIC EFFECT; ASTHMA; ATOPIC DERMATITIS; BRONCHOSPASM; CARDIOTOXICITY; CHRONIC URTICARIA; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; GASTROINTESTINAL SYMPTOM; HUMAN; INTRANASAL DRUG ADMINISTRATION; MUCOSA INFLAMMATION; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATORY TRACT DISEASE; REVIEW; TASTE DISORDER; WEIGHT GAIN; ANIMAL; HYPERSENSITIVITY;

ANIMAL; HISTAMINE H1 ANTAGONISTS; HUMAN; HYPERSENSITIVITY;

EID: 0028182504     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199406093302307     Document Type: Review

References (102)

1. Simons FER, Simons KJ. Antihistamines. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. Vol. 1. St. Louis: Mosby-Year Book, 1993:856-92.
2. Casy AF. Antagonists of H1 receptors of histamine: recent developments. In: Uvnas B, ed. Histamine and histamine antagonists. No. 97 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1991:549-72.
3. Pearce FL Biological effects of histamine: an overview. Agents Actions 1991; 33: 4-7
4. Hill SJ Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol Rev 1990; 42: 45-83
5. Levi R, Rubin LE, Gross SS. Histamine in cardiovascular function and dysfunction: recent developments. In: Uvnas B, ed. Histamine and histamine antagonists. No. 97 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1991:347-83.
6. Ter Laak AM, Donne-Op den Kelder GM, Bast A, Timmerman H Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study. Eur J Pharmacol 1993; 232: 199-205
7. Ruat M, Bouthenet ML, Schwartz J-C, Ganellin CR Histamine H1-receptor in heart: unique electrophoretic mobility and autoradiographic localization. J Neurochem 1990; 55: 379-385
8. De Backer MD, Gommeren W, Moereels H, Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. Biochem Biophys Res Commun 1993; 197: 1601-1608
9. Chowdhury BA, Kaliner MA, Fraser CM Cloning of a gene encoding the human H1 histamine receptor. J Allergy Clin Immunol 1994; 93: 215-215 abstract.
10. Timmerman H. Factors involved in the incidence of central nervous system effects of H1-blockers. In: Church MK, Rihoux J-P, eds. Therapeutic index of antihistamines. Lewiston, N.Y.: Hogrefe & Huber, 1992:19-31.
11. Nicholson AN, Pascoe PA, Turner C, Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 1991; 104: 270-276
12. Zhang MQ, ter Laak AM, Timmerman H Structure-activity relationships within a series of analogues of the histamine H1-antagonist terfenadine. Eur J Med Chem 1993; 28: 165-173
13. White MV The role of histamine in allergic diseases. J Allergy Clin Immunol 1990; 86: 599-605
14. Simons FER, Murray HE, Yi Z, Simons KJ Cetirizine and hydroxyzine concentrations in human skin. J Allergy Clin Immunol 1994; 93: 222-222 abstract.
15. Rimmer SJ, Church MK The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy 1990; 20: Suppl 2: 3-17
16. Bousquet J, Campbell A, Michel F-B. Antiallergic activities of antihistamines. In: Church MK, Rihoux J-P, eds. Therapeutic index of antihistamines. Lewiston, N.Y.: Hogrefe & Huber, 1992:57-84.
17. Bousquet J, Lebel B, Chanal I, Morel A, Michel F-B Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988; 82: 881-887
18. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990; 142: 167-171
19. Michel L, De Vos C, Rihoux J-P, Burtin C, Benveniste J, Dubertret L Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988; 82: 101-109
20. Charlesworth EN, Kagey-Sobotka A, Norman PS, Lichtenstein LM Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1989; 83: 905-912
21. Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM The effect of cetirizine on early allergic response. Laryngoscope 1989; 99: 596-599
22. Klementsson H, Andersson M, Pipkorn U Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 1990; 86: 466-472
23. McTavish D, Goa KL, Ferrill M Terfenadine: an updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990; 39: 552-574
24. Janssens MM-L Astemizole: a nonsedating antihistamine with fast and sustained activity. Clin Rev Allergy 1993; 11: 35-63
25. Clissold SP, Sorkin EM, Goa KL Loratadine: a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1989; 37: 42-57
26. Spencer CM, Faulds D, Peters DH Cetirizine: a reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993; 46: 1055-1080
27. Grant SM, Goa KL, Fitton A, Sorkin EM Ketotifen: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 1990; 40: 412-448 [Erratum, Drugs 1991;41:192.]
28. McTavish D, Sorkin EM Azelastine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 1989; 38: 778-800
29. Dechant KL, Goa KL Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 1991; 41: 202-224
30. Brogden RN, McTavish D Acrivastine: a review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders. Drugs 1991; 41: 927-940 [Erratum, Drugs 1991;42:639.]
31. Paton DM, Webster DR Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines). Clin Pharmacokinet 1985; 10: 477-497
32. Simons FER, Simons KJ Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy. Clin Pharmacokinet 1991; 21: 372-393
33. Simons KJ, Watson WTA, Chen XY, Simons FER Pharmacokinetic and pharmacodynamic studies of the H1-receptor antagonist hydroxyzine in the elderly. Clin Pharmacol Ther 1989; 45: 9-14
34. Simons FER, Watson WTA, Chen XY, Minuk GY, Simons KJ The pharmacokinetics and pharmacodynamics of hydroxyzine in patients with primary biliary cirrhosis. J Clin Pharmacol 1989; 29: 809-815
35. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992; 52: 231-238
36. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR Terfenadine-ketoconazole interaction: pharmacokinetic and electrocardiographic consequences. JAMA 1993; 269: 1513-1518 [Erratum, JAMA 1993;269:2088.]
37. Gengo FM, Dabronzo J, Yurchak A, Love S, Miller JK The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther 1987; 42: 265-272
38. Watson WTA, Simons KJ, Chen XY, Simons FER Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84: 457-464
39. Matzke GR, Yeh J, Awni WM, Halstenson CE, Chung M Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy 1987; 59: 25-30
40. Howarth PH, Emanuel MB, Holgate ST Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol 1984; 18: 1-8
41. Simons FER, McMillan JL, Simons KJ A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990; 86: 540-547
42. Labrecque M, Ghezzo H, L'Archeveque J, Trudeau C, Cartier A, Malo J-L Duration of effect of loratadine and terfenadine administered once a day for one week on cutaneous and inhaled reactivity to histamine. Chest 1993; 103: 777-781
43. Lantin JP, Huguenot CH, Pecoud A Effect of the H1-antagonist astemizole on the skin reactions induced by histamine, codeine, and allergens. Curr Ther Res 1990; 47: 683-692
44. Malo J-L, Fu CL, L'Archeveque J, Ghezzo H, Cartier A Duration of the effect of astemizole on histamine-inhalation tests. J Allergy Clin Immunol 1990; 85: 729-736
45. Bantz EW, Dolen WK, Chadwick EW, Nelson HS Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and compliance. Ann Allergy 1987; 59: 341-346
46. Simons FER, Watson WTA, Simons KJ Lack of subsensitivity to terfenadine during long-term terfenadine treatment. J Allergy Clin Immunol 1988; 82: 1068-1075
47. Bousquet J, Chanal I, Skassa-Brociek W, Lemonier C, Michel FB Lack of subsensitivity to loratadine during long-term dosing during 12 weeks. J Allergy Clin Immunol 1990; 86: 248-253
48. Juniper EF, White J, Dolovich J Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1988; 82: 670-675
49. Levander S, Stahle-Backdahl M, Hagermark O Peripheral antihistamine and central sedative effects of single and continuous oral doses of cetirizine and hydroxyzine. Eur J Clin Pharmacol 1991; 41: 435-439
50. Goetz DW, Jacobson JM, Murnane JE, Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol 1989; 84: 316-322
51. Stern MA, Rosenberg RM, Smith R, Fidler C A comparative study of terfenadine at two dose levels in the management of hayfever. Br J Clin Pract 1990; 44: 359-363
52. Falliers CJ, Brandon ML, Buchman E, Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991; 66: 257-262
53. Del Carpio J, Kabbash L, Turenne Y, Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 84: 741-746
54. Gibbs TG, McDonnell KA, Stokes T, Graham AA Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. Br J Clin Pract 1989; 43: 11-14
55. Brooks CD, Karl KJ, Francom SF Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990; 20: 21-26
56. Weiler JM, Meltzer EO, Dockhorn R, Widlitz MD, D'Eletto TA, Freitag JJ A safety and efficacy evaluation of azelastine (AZ) nasal spray (NS) in seasonal allergic rhinitis (SAR). J Allergy Clin Immunol 1991; 87: 219-219 abstract.
57. Frostad AB, Olsen AK A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis. Clin Exp Allergy 1993; 23: 406-409
58. Storms WW, Bodman SF, Nathan RA, SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol 1989; 83: 1083-1090
59. Orgel HA, Meltzer EO, Kemp JP, Ostrom NK, Welch MJ Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. Ann Allergy 1991; 66: 237-244
60. Juniper EF, Kline PA, Hargreave FE, Dolovich J Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989; 83: 627-633
61. Smith MBH, Feldman W Over-the-counter cold medications: a critical review of clinical trials between 1950 and 1991. JAMA 1993; 269: 2258-2263
62. Gaffey MJ, Kaiser DL, Hayden FG Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms. Pediatr Infect Dis J 1988; 7: 223-228
63. Cantekin EI, Mandel EM, Bluestone CD, Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretory“ otitis media) in children: results of a double-blind, randomized trial. N Engl J Med 1983; 308: 297-301
64. Rafferty P, Holgate ST Histamine and its antagonists in asthma. J Allergy Clin Immunol 1989; 84: 144-151
65. Rafferty P, Holgate ST Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987; 135: 181-184
66. Town GI, Holgate ST Comparison of the effect of loratadine on the airway and skin responses to histamine, methacholine, and allergen in subjects with asthma. J Allergy Clin Immunol 1990; 86: 886-893
67. Brik A, Tashkin DP, Gong H Jr, Dauphinee B, Lee E Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol 1987; 80: 51-56
68. Rafferty P, Jackson L, Smith R, Holgate ST Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma. Br J Clin Pharmacol 1990; 30: 229-235
69. Dijkman JH, Hekking PRM, Molkenboer JF, Prophylactic treatment of grass pollen-induced asthma with cetirizine. Clin Exp Allergy 1990; 20: 483-490
70. Grant JA, Bernstein DI, Buckley CE, Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1988; 81: 574-579
71. Brunet C, Bedard P-M, Hebert J Effects of H1-antihistamine drug regimen on histamine release by nonlesional skin mast cells of patients with chronic urticaria. J Allergy Clin Immunol 1990; 86: 787-793
72. Cainelli T, Seidenari S, Valsecchi R, Mosca M Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. Pharmatherapeutica 1986; 4: 679-686
73. Juhlin L, Arendt C Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br J Dermatol 1988; 119: 67-71
74. Belaich S, Bruttmann G, DeGreef H, Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990; 64: 191-194
75. Yang WH, Drouin MA, Copeland D, Double-blind multicentre study of ketotifen (Zaditen) in chronic idiopathic urticaria. J Allergy Clin Immunol 1991; 87: 224-224 abstract.
76. Advenier C, Queille-Roussel C Rational use of antihistamines in allergic dermatological conditions. Drugs 1989; 38: 634-644
77. Bleehen SS, Thomas SE, Greaves MW, Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987; 117: 81-88
78. Paul E, Bodeker RH Treatment of chronic urticaria with terfenadine and ranitidine: a randomized double-blind study in 45 patients. Eur J Clin Pharmacol 1986; 31: 277-280
79. Simons FER, Sussman GL, Simons KJ. Effect of the H1-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol (in press).
80. Marshall C, Lieberman P Analysis of 3 pretreatment procedures to prevent anaphylactoid reactions to radiocontrast (RCM) in previous reactors (R). J Allergy Clin Immunol 1989; 83: 254-254 abstract.
81. Lorenz W, Ennis M, Doenicke A, Dick W Perioperative uses of histamine antagonists. J Clin Anesth 1990; 2: 345-360 [Erratum, J Clin Anesth 1991;3:170.]
82. Berth-Jones J, Graham-Brown RAC Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989; 121: 635-637
83. Meltzer EO Comparative safety of H1 antihistamines. Ann Allergy 1991; 67: 625-633
84. Simons FER H1-receptor antagonists: comparative tolerability and safety. Drug Saf 1994; 10: 350-380
85. Huxtable RF, Landwirth J Diphenhydramine poisoning treated by exchange transfusion. Am J Dis Child 1963; 106: 496-500
86. Hollister LE Hydroxyzine hydrochloride: possible adverse cardiac interactions. Psychopharmacol Commun 1975; 1: 61-65
87. Goetz DW, Jacobson JM, Apaliski SJ, Repperger DW, Martin ME Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991; 67: 448-454
88. Alford C, Rombaut N, Jones J, Foley S, Idzikowski C, Hindmarch I Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study. Hum Psychopharmacol 1992; 7: 25-35
89. Seidel WF, Cohen S, Bliwise NG, Dement WC Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electroencephalographic assessment. J Allergy Clin Immunol 1990; 86: 1029-1033
90. Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. J Forensic Sci 1982; 27: 855-867
91. Bhatti JZ, Hindmarch I The effects of terfenadine with and without alcohol on an aspect of car driving performance. Clin Exp Allergy 1989; 19: 609-611
92. Bradley CM, Nicholson AN Studies on the central effects of the H1-antagonist, loratadine. Eur J Clin Pharmacol 1987; 32: 419-421
93. Rombaut N, Bhatti JZ, Curran S, Hindmarch I Effects of topical administration of levocabastine on psychomotor and cognitive function. Ann Allergy 1991; 67: 75-79
94. Meador KJ, Loring DW, Thompson EE, Thompson WO Differential cognitive effects of terfenadine and chlorpheniramine. J Allergy Clin Immunol 1989; 84: 322-325
95. Woosley RL, Chen Y, Freiman JP, Gillis RA Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993; 269: 1532-1536
96. Rampe D, Wible B, Brown AM, Dage RC Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993; 44: 1240-1245
97. Hanrahan JP, Choo PW, Carlson W, Greineder D, Faich GA, Platt R Antihistamine-associated sudden death, ventricular arrhythmias, syncope and QT-interval prolongation: a comparison of terfenadine and other antihistamines. Post Mark Surveillance 1992; 6: 23-24
98. Pratt CM, Hertz RP, Ellis BE, Crowell SP, Louv W, Moye L Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine. Am J Cardiol 1994; 73: 346-352
99. Affrime MB, Lorber R, Danzig M, Cuss F, Brannan MD Three month evaluation of electrocardiographic effects of loratadine in humans. J Allergy Clin Immunol 1993; 91: 259-259 abstract.
100. Sale ME, Woosley RL, Barby JT, Yeh J, Chung M Lack of electrocardiographic effects of cetirizine in healthy humans. J Allergy Clin Immunol 1993; 91: 258-258 abstract.
101. Sanders RL, Dockhorn RJ, Alderman JL, McSorley PA, Wenger TL, Frosolono MF Cardiac effects of acrivastine compared to terfenadine. J Allergy Clin Immunol 1992; 89: 183-183 abstract.
102. Schatz M, Hoffman CP, Zeiger RS, Falkoff R, Macy E, Mellon M. The course and management of asthma and allergic diseases during pregnancy. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds. Allergy: principles and practice. 4th ed. Vol. 2. St. Louis: Mosby-Year Book, 1993:1301-42.